Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

EW

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

EW

AI Research Report

Powered by Claude

Ready to analyze EW

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

Factor Grades

View details →
C+
Overall score: 55/100
C-
Valuation
C
Growth
B
Profitability
C-
Momentum
B
Financial Health
  • Yahoo·1d ago

    Top Stock Reports for Eli Lilly, Mastercard & AMD

    Eli Lilly rides strong GLP-1 demand and pipeline momentum, while Mastercard and AMD navigate mixed performance and rising competition pressures.

  • Yahoo·4d ago

    Citi Cuts Medtronic (MDT) Target, Stifel Lowers Outlook after MiniMed IPO

    Medtronic plc (NYSE:MDT) is included among the 15 Best Cheap Dividend Stocks to Buy. On April 7, Citi analyst Joanne Wuensch lowered the firm’s price target on Medtronic plc (NYSE:MDT) to $110 from $117 and kept a Buy rating. The update came as part of a Q1 preview for the medical technology group. The analyst […]

  • Yahoo·6d ago

    Tired of AI and Oil? Buy the Robot.

    Intuitive Surgical (ISRG) is currently hovering around the $450 mark, a level that has historically acted as a psychological and technical floor. For an investor, the question isn't just "is it cheap?" (it almost never is), but "is the premium still justified?”.

  • Yahoo·6d ago

    Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now

    Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Low Volatility Blue Chip Stocks to Buy Now. On April 7, Citi lifted its price recommendation on Johnson & Johnson (NYSE:JNJ) to $285 from $274. The firm kept a Buy rating as it updated its outlook for the medical technology group ahead of Q1. The […]

  • View all news →
Edwards Lifesciences Corp

Edwards Lifesciences Corp

Health Care·NEW YORK STOCK EXCHANGE, INC.·US·IPO 2000-03-27
📅 Earnings in 14d (Apr 29)
NEW YORK STOCK EXCHANGE, INC.Market closed
Edwards Lifesciences Corp
Health Care
$78.20
$0.08 (+0.10%)
Open
$77.84
Prev close
$78.12
Day range
$77.33 – $78.90
52W range
$66.77 – $87.89
Mkt cap
$45.09B
P/E
42.1
EPS
$1.83
Beta
0.87

Fundamentals

Valuation
Market Cap
$45.09B
P/E (TTM)
42.12S&P avg ~22
P/S (TTM)
7.45S&P avg ~2.8
P/B
4.79S&P avg ~4.5
P/FCF
33.87S&P avg ~26
EPS (TTM)
$1.83
Book/sh
$17.80
Cash/sh
$7.28
Profitability
Gross Margin
78.01%avg ~45%
Operating Margin
18.41%avg ~15%
Net Margin
17.69%avg ~12%
ROE
10.42%avg ~18%
ROA
8.03%avg ~7%
ROI
9.85%
Payout Ratio
—
FCF/sh
—
Growth & Health
Rev Growth YoY
6.00%
Rev Growth 5Y
6.70%
EPS Growth YoY
-73.77%
EPS Growth 5Y
7.06%
Current Ratio
—
Quick Ratio
3.02
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
0.87
52W High
$87.89
52W Low
$66.77
Avg Vol (10D)
4.58M
Avg Vol (3M)
4.20M
Div Yield
—
Div/sh (TTM)
—
Analyst
Buy (43)
Price Performance
5D-3.36%
MTD-2.45%
3M-7.64%
6M+2.04%
YTD-8.36%
1Y+14.44%

Analyst Consensus

Buy
Based on 43 analysts
Period: 2026-04-01
31 Buy (72%)12 Hold (28%)0 Sell (0%)
Rating Distribution
Strong Buy
11
Buy
20
Hold
12
Sell
0
Strong Sell
0
Trend
2026-04
31/12/0
2026-03
31/12/0
2026-02
31/12/0
2026-01
30/12/0

Recent insider activity

View all →
  • 4Insider transaction
    6d ago
  • 4Insider transaction
    9d ago
  • 4Insider transaction
    13d ago
  • 4Insider transaction
    Mar 11
  • 4Insider transaction
    Mar 11